Evidence map›Paper›PMID 27756394›Full record

ArticleMalaria journal2016

Malaria incidence in Myanmar 2005-2014: steady but fragile progress towards elimination.

Thet Thet Mu, Aye Aye Sein, Tint Tint Kyi, Myo Min, Ne Myo Aung, Nicholas M Anstey, Myat Phone Kyaw, Chit Soe, Mar Mar Kyi, Josh Hanson

Open access · goldAbstract read
In one paragraph

Article in Malaria journal, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed
35.4field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 338 citations in OpenAlex.

  1. Parasite epidemiology and control · 2026
    Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Temporal Changes in the Genetic Diversity ofPathogens (Basel, Switzerland) · 2021
    Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Observational
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 5 institutions in 3 countries.

Thet Thet MuDepartment of Public Health, Ministry of Health, Nay Pyi Taw, Myanmar.
Aye Aye SeinDepartment of Public Health, Ministry of Health, Nay Pyi Taw, Myanmar.
Tint Tint KyiDepartment of Medical Care, Ministry of Health, Nay Pyi Taw, Myanmar.
Myo MinMyanmar Medical Association, Yangon, Myanmar.
Ne Myo AungUniversity of Medicine 2, Yangon, Myanmar.
Nicholas M AnsteyMenzies School of Health Research, Darwin, Australia.
Myat Phone KyawDepartment of Medical Research, Yangon, Myanmar.
Chit SoeUniversity of Medicine 1, Yangon, Myanmar.
Mar Mar KyiUniversity of Medicine 2, Yangon, Myanmar.
Josh HansonUniversity of Medicine 2, Yangon, Myanmar. drjoshhanson@gmail.com.ORCID http://orcid.org/0000-0002-1423-3839
Ministry of Health and Sports · MMMenzies School of Health Research · AUUniversity of Medicine 2 Yangon · MMMyanmar Oxford Clinical Research Unit · MMUniversity Of Medicine 1 Yangon · MM

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThere has been an impressive recent reduction in the global incidence of malaria, but the development of artemisinin resistance in the Greater Mekong Region threatens this progress. Increasing artemisinin resistance is particularly important in Myanmar, as it is the country in the Greater Mekong Region with the greatest malaria burden. If malaria is to be eliminated in the region, it is essential to define the spatial and temporal epidemiology of the disease in Myanmar to inform control strategies optimally.

resultsBetween the years 2005 and 2014 there was an 81.1 % decline in the reported annual incidence of malaria in Myanmar (1341.8 cases per 100,000 population to 253.3 cases per 100,000 population). In the same period, there was a 93.5 % decline in reported annual mortality from malaria (3.79 deaths per 100,000 population to 0.25 deaths per 100,000 population) and a 87.2 % decline in the proportion of hospitalizations due to malaria (7.8 to 1.0 %). Chin State had the highest reported malaria incidence and mortality at the end of the study period, although socio-economic and geographical factors appear a more likely explanation for this finding than artemisinin resistance. The reduced malaria burden coincided with significant upscaling of disease control measures by the national government with support from international partners. These programmes included the training and deployment of over 40,000 community health care workers, the coverage of over 60 % of the at-risk population with insecticide-treated bed nets and significant efforts to improve access to artemesinin-based combination treatment. Beyond these malaria-specific programmes, increased general investment in the health sector, changing population demographics and deforestation are also likely to have contributed to the decline in malaria incidence seen over this time.

conclusionsThere has been a dramatic fall in the burden of malaria in Myanmar since 2005. However, with the rise of artemisinin resistance, continued political, financial and scientific commitment is required if the ambitious goal of malaria elimination in the country is to be realized.

Indexed as

AntimalarialsArtemisininsDrug ResistanceHumansIncidenceLactonesMalariaMyanmarPlasmodiumSurvival AnalysisAntimalarialsartemisinArtemisininsLactonesArtemisinin resistanceEpidemiologyGreater Mekong RegionMalariaMyanmarPublic health

Identifiers

PMID27756394
PMCPMC5069869
OpenAlexW2536582940

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.